ALK inhibition for the treatment of refractory epithelioid inflammatory myofibroblastic sarcoma

Intern Med. 2014;53(19):2177-8. doi: 10.2169/internalmedicine.53.3038.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anaplastic Lymphoma Kinase
  • DNA, Neoplasm / genetics
  • Enzyme Inhibitors / therapeutic use*
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Middle Aged
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptor Protein-Tyrosine Kinases / genetics
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcoma / drug therapy*
  • Sarcoma / enzymology
  • Sarcoma / genetics

Substances

  • DNA, Neoplasm
  • Enzyme Inhibitors
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases